COBI (COntinuous hyperosmolar therapy for traumatic Brain-Injured patients) trial protocol: a multicentre randomised open-label trial with blinded adjudication of primary outcome

INTRODUCTION: Traumatic brain injury (TBI) is a major cause of death and severe prolonged disability. Intracranial hypertension (ICH) is a critical risk factor of bad outcomes after TBI. Continuous infusion of hyperosmolar therapy has been proposed for the prevention and the treatment of ICH. Whethe...

Descripción completa

Detalles Bibliográficos
Autores principales: Roquilly, Antoine, Lasocki, Sigismond, Moyer, Jean Denis, Huet, Olivier, Perrigault, Pierre François, Dahyot-fizelier, Claire, Seguin, Philippe, Sharshar, Tarek, Geeraerts, Thomas, Remerand, Francis, Feuillet, Fanny, Asehnoune, Karim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2017
Materias:
Intensive Care
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5623466/
https://www.ncbi.nlm.nih.gov/pubmed/28947465
http://dx.doi.org/10.1136/bmjopen-2017-018035

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5623466/
https://www.ncbi.nlm.nih.gov/pubmed/28947465
http://dx.doi.org/10.1136/bmjopen-2017-018035

Ejemplares similares